Bio-Gene Technology
(ASX) BGT
Bio-Gene Technology Financials at a Glance
Market Cap
$9.46M
Revenue (TTM)
$435.00
Net Income (TTM)
$4.33M
EPS (TTM)
$-0.01
P/E Ratio
-3.26
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$0.03
Volume
0
Open
$0.03
Price
$0.03
Volume
0
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.06
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$0.03
Volume
0
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.06
BGT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio-Gene Technology
Industry
Chemicals
Sector
MaterialsCEO
Tim Grogan
Website
bio-gene.com.auHeadquarters
Melbourne, VIC 3000, AU
BGT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-202%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
-30.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.46M
Shares Outstanding
305.06M
Volume
0
Short Interest
0.00%
Avg. Volume
100.77K
Financials (TTM)
Gross Profit
$245.78K
Operating Income
$3.07M
EBITDA
$2.58M
Operating Cash Flow
$2.54M
Capital Expenditure
$0.00
Free Cash Flow
$2.54M
Cash & ST Invst.
$1.14M
Total Debt
$51.21K
Bio-Gene Technology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$20.85K
+87.8%
Gross Margin
0.00%
N/A
Market Cap
$9.46M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.40M
+7.2%
EBITDA
$2.77M
-80.6%
Quarterly Fundamentals
Net Cash
$1.08M
-66.5%
Accounts Receivable
$29.28K
-94.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.33%
N/A
Return on Invested Capital
-3.73%
N/A
Free Cash Flow
$946.61K
+45.8%
Operating Cash Flow
$946.61K
+45.8%